Rocket Lab shares plunge 8%: What’s behind the selloff?
1/6
Rocket Lab stock tumbles
Rocket Lab shares slumped on October 14 after the company pushed back the maiden flight of its Neutron rocket to 2027. The delay has raised fresh concerns about execution risks and the timeline for expanding into the medium-lift launch market. (Sources: Stocktwits, MarketBeat)
2/6
Manufacturing problems delay key rocket milestone
The revised timeline follows manufacturing challenges involving Neutron's forward dome, a critical component of the rocket's structure. Rocket Lab said the replacement component needs to be completed and tested before the company proceeds with further tank assembly and testing, pushing the launch programme into next year.
3/6
Shares retreat sharply from record highs
Rocket Lab closed at $59.18 on October 14, down 7.85% for the session, according to Yahoo Finance. The stock has retreated significantly from its 52-week high of $151, reflecting pressure on a high-growth space company as investors reassess its valuation and development milestones.
4/6
Electron business offers a counterweight to Neutron risks
Rocket Lab's existing Electron rocket continues to serve the small-satellite launch market, while the company's broader space-systems business supplies spacecraft and components. Its second-quarter 2026 revenue rose 62% year on year to $234 million, and its backlog reached a record $2.36 billion, providing evidence of demand beyond the delayed Neutron programme.
5/6
Iridium deal adds another dimension to growth plans
Rocket Lab's proposed acquisition of satellite communications company Iridium is part of its ambition to expand beyond launch services into a more vertically integrated space business. Investors will be watching the transaction's execution, funding implications and potential strategic benefits alongside the Neutron delay.
6/6
What should investors watch next?
Investors will be looking for progress on Neutron's component testing, first-stage tank assembly and a firmer launch schedule. Revenue growth, backlog conversion, cash consumption and the funding requirements of the Iridium transaction will also be important in assessing whether Rocket Lab can sustain its long-term growth ambitions. The delayed debut adds uncertainty, but does not by itself determine the company's long-term prospects.
(Disclaimer: This slideshow is based on inputs from agencies. These do not represent the views of The Economic Times.)
(Disclaimer: This slideshow is based on inputs from agencies. These do not represent the views of The Economic Times.)